drugset / Trial / NCT02129985
Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy
Phase 4
Unknown
100 enrolled
xiaolong zhao
Fuling Central Hospital of Chongqing City · collabSecond Affiliated Hospital of Soochow University · collabShanghai Pudong New Area Gongli Hospital · collabShanghai Zhongshan Hospital · collabTaizhou Hospital · collabThe First Hospital of Guiyang Medical college · collabThe third people's Hospital Affiliated to Shanghai Jiao Tong University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Whether GLP-1 receptor agonists sequential therapy in newly diagnosed type 2 diabetic patients can further improve glycemic control, diabetes remission rate and β-cell function after the short-term insulin intensive therapy.
Timeline
- Start
- 2014-02
- Primary completion
- 2015-06
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | 10 ug | — |
| Comparator | Metformin | Small molecule | 850 mg | — |